GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts-Reference-Cited by-同舟云学术

GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts

Published:2017-08-07 Issue:10 Volume:141 Page:2131-2142
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bernier Michel¹,Catazaro Jonathan²,Singh Nagendra S.³,Wnorowski Artur⁴,Boguszewska-Czubara Anna⁵,Jozwiak Krzysztof⁴,Powers Robert²,Wainer Irving W.³⁶^ORCID

Affiliation:

1. Translational Gerontology Branch, Intramural Research Program of the National Institute on Aging, National Institutes of Health; Baltimore MD 21224

2. Department of Chemistry; University of Nebraska-Lincoln; Lincoln NE 68588-0304

3. Laboratory of Clinical Investigation; Intramural Research Program of the National Institute on Aging, National Institutes of Health; Baltimore MD 21224

4. Department of Biopharmacy; Medical University of Lublin; Lublin 20-093 Poland

5. Department of Medical Chemistry; Medical University of Lublin; Lublin 20-093 Poland

6. Mitchell Woods Pharmaceuticals; Shelton CT 06484

Funder

Intramural Research Program of the National Institute on Aging at NIH, from the National Institutes of Health

Nebraska Center for Integrated Biomolecular Communication Systems Biology Core, NIH National Institutes of General Medical Sciences

National Institutes of Health

NIH Public Access Policy

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference60 articles.

1. On the origin of cancer cells;Warburg;Science,1956

2. Glycolysis inhibition for anticancer treatment;Pelicano;Oncogene,2006

3. Tumor glycolysis as a target for cancer therapy: progress and prospects;Ganapathy-Kanniappan;Mol Cancer,2013

4. Targeting glucose metabolism for cancer therapy;Hamanaka;J Exp Med.,2012

5. Metabolic changes in cancer: beyond the Warburg effect;Wu;Acta Biochim Biophys Sin (Shanghai).,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. REEP3 as a Novel Oncogene Contributes to the Warburg Effect in Pancreatic Cancer Cells by Activating the EGFR/ERK Pathway;Molecular Biology;2024-01-21

2. Potential application of nanotechnology in the treatment and overcoming of pancreatic cancer resistance;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

3. Modulation of PI3K/Akt/GSK3β signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction;Life Sciences;2023-12

4. A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activators against pancreatic cancer;Acta Pharmaceutica Sinica B;2023-10

5. Steroidal saponins PPI/CCRIS/PSV induce cell death in pancreatic cancer cell through GSDME-dependent pyroptosis;Biochemical and Biophysical Research Communications;2023-09